Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease Post author: Post published:April 25, 2024 Post category:uncategorized Funding represents the first time the foundation has taken an equity position in a breath diagnostics company. You Might Also Like The relationship between tobacco smoking, all-cause mortality, and premature death December 14, 2023 Salt and Diabetes: Does Sodium Affect Blood Sugar? February 27, 2024 Novel and emerging therapies offer new hope for patients with inflammatory bowel disease November 7, 2023
Novel and emerging therapies offer new hope for patients with inflammatory bowel disease November 7, 2023